Figure 2 from Characterization of the Immunogenomic Landscape of Ovarian Cancer Uncovers a Distinct Subset of Endometroid Tumors Associated with High CST2 Expression and a Favorable Prognosis
Abstract
Beeswarm plots of the MOFA latent variables in each subtype. Variable 1: Density of PD-1 and PD-L1 positivity in TC and IM; variable 2: expression of MHC-II antigen presentation pathway genes; variable 3: density of CD8+ and CD68+ cells in IM; variable 4: mutually exclusive mutations in tumors; variable 5: difference between density of CD8+ T cells and PD-L1+ tumor cells across tumor; variable 6: expression of specific chemokine-related genes; variable 7: expression of specific collagen-related genes; variable 8: expression of CST2; variable 9: expression of specific interferon-related genes; and variable 10: expression of COL11A1.
Fields of Study & Subjects
Ovarian cancer diagnosis and treatment
Cancer Immunotherapy and Biomarkers
Endometrial and Cervical Cancer Treatments
Publication details
- Publication date
- 28 January 2026